Companies: 10,795·Total market cap: $144.5T
ProPhase Labs, Inc.

ProPhase Labs, Inc.

PRPHNASDAQHealthcare● Active
$0.10
$-0.01(-9.09%)
Market Cap$473701
P/E Ratio
52W High$6.7
52W Low$0.07

ProPhase Labs, Inc.(PRPH)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PRPH · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$4.34M$6.77M$44.38M$122.65M$79.04M
Cost of Revenue$2.96M$6.92M$28.14M$51.99M$46.23M
Gross Profit$1.38M($0.15M)$16.24M$70.65M$32.81M
Gross Margin %(computed)31.85%-2.22%36.59%57.61%41.51%
Operating Expenses
R&D Expenses$0.11M$0.59M$1.42M$0.65M$0.52M
G&A Expenses$19.32M$37.88M$34.50M$46.41M$22.49M
Total Operating Expenses$19.43M$38.48M$37.85M$47.06M$23.01M
Operating Income($18.05M)($38.63M)($21.61M)$23.59M$9.80M
Operating Margin %(computed)-415.35%-570.59%-48.70%19.24%12.40%
Interest Income$0.00M$0.00M$0.08M$0.15M$0.64M
Interest Expense$6.93M$3.35M$1.27M$0.76M$1.15M
Income Before Tax($23.39M)($42.33M)($22.40M)$22.91M$5.30M
Income Tax Expense($8.64M)$7.20M($6.02M)$4.45M($0.97M)
Net Income($14.74M)($53.36M)($16.78M)$18.46M$6.27M
Net Margin %(computed)-339.31%-788.24%-37.81%15.05%7.94%
Per Share & EBITDA
EPS (Basic)$-1.74$-26.10$-9.80$11.70$4.10
Wtd Avg Shares8.49M1.91M1.72M1.58M1.52M
EBITDA($11.39M)($32.34M)($14.83M)$28.73M$11.39M
EBITDA Margin %(computed)-262.26%-477.64%-33.41%23.43%14.41%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解ProPhase Labs, Inc.

关于ProPhase Labs, Inc.(PRPH)损益表

ProPhase Labs, Inc.(PRPH)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,PRPH实现营收$0.00B,毛利润$0.00B(毛利率31.85%),净利润($0.01B)(净利率-339.31%)。

常见问题

PRPH · 4 问

ProPhase Labs, Inc.(PRPH)2025财年营收为$0.00B,同比down35.8%。

PRPH revenuePRPH salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09